Danaher (DHR) Directors and Executive Officers - CSIMarket
CSIMarket
 
Danaher Corporation  (NYSE: DHR)
    Sector  Technology    Industry IT Infrastructure
   Industry IT Infrastructure
   Sector  Technology

Danaher Corporation

Officers & Directors


WALTER G. LOHR, JR.

CHRISTOPHER M. BOUDA

RAINER M. BLAIR
President and Chief Executive Officer

ALAN G. SPOON

A. SHANE SANDERS

JOHN T. SCHWIETERS

STEVEN M. RALES

LINDA FILLER

FEROZ DEWAN

MITCHELL P. RALES

MATTHEW R. MCGREW

ELIAS A. ZERHOUNI, M.D.

PARDIS C. SABETI, M.D., D.Phil

TERI LIST

RAYMOND C. STEVENS, Ph.D.

JESSICA L. MEGA, M.D., MPH ,

Danaher Corporation currently has 60000 employees.

  News about Danaher Corporation Key Personnel

Molecular Devices Elects Mary Duseau as President, Spearheading a New Era of Innovation and Growth

Molecular Devices Appoints Mary Duseau as President, Bringing 25 Years of Experience in Life Sciences
Molecular Devices, a prominent provider of high-performance life science solutions and an operating company within the life sciences segment of Danaher Corporation, has made a significant leadership change. Today, the company announced the appointment of Mary Duseau as its new president, taking over from interim president Greg Milosevich.
Duseau brings an impressive 25 years of experience in the field of life sciences to her new role. Prior to joining Molecular Devices, she held various key positions in notable organizations within the industry. Her extensive expertise and leadership capabilities m...






DHR Management Effectiveness DHR Revenue per Employee DHR Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.